These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18200037)

  • 1. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
    Pasqualucci L; Li S; Meloni G; Schnittger S; Gattenlohner S; Liso A; Di Ianni M; Martelli MP; Pescarmona E; Foa R; Haferlach T; Skoda RC; Falini B
    Leukemia; 2008 Jul; 22(7):1459-63. PubMed ID: 18200037
    [No Abstract]   [Full Text] [Related]  

  • 2. The decrease of JAK2 V617F allele burden in leukemia transformation of an elderly patient with myelofibrosis.
    Zhang SJ; Li JY; Zhang JF; Finn J; Lu H; Xu W; Qian SX; Wu HX
    Leuk Res; 2009 Aug; 33(8):e116-8. PubMed ID: 19328546
    [No Abstract]   [Full Text] [Related]  

  • 3. Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis.
    Kreft A; Springer E; Lipka DB; Kirkpatrick CJ
    Acta Haematol; 2009; 122(1):36-8. PubMed ID: 19713696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2(V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia.
    Mesa RA; Powell H; Lasho T; Dewald G; McClure R; Tefferi A
    Leuk Res; 2006 Nov; 30(11):1457-60. PubMed ID: 16563504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.
    Roug AS; Nyvold CG; Juhl-Christensen C; Christensen M; Schnittger S; Hokland P
    Eur J Haematol; 2011 Nov; 87(5):461-3. PubMed ID: 21689158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemia.
    Yoshiki Y; Asai T; Ichikawa M; Hangaishi A; Ota S; Imai Y; Takahashi T; Kurokawa M
    Intern Med; 2011; 50(21):2649-52. PubMed ID: 22041374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ; Rosillo C; Camoriano JK
    Am J Hematol; 2007 May; 82(5):400-2. PubMed ID: 17133423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.
    Park SH; Chi HS; Shim H; Jang S; Park CJ
    Int J Lab Hematol; 2013 Feb; 35(1):e1-3. PubMed ID: 22978565
    [No Abstract]   [Full Text] [Related]  

  • 9. Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.
    Fiorini A; Reddiconto G; Farina G; Marietti S; Palladino M; Chiusolo P; Leone G; Sica S
    Leukemia; 2006 Dec; 20(12):2198-9. PubMed ID: 17039230
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent der(9;18) in essential thrombocythemia with JAK2 V617F is highly linked to myelofibrosis development.
    Ohyashiki K; Kodama A; Ohyashiki JH
    Cancer Genet Cytogenet; 2008 Oct; 186(1):6-11. PubMed ID: 18786436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation.
    Wu YY; Hung HM; Chen TS; Chao TY; Ho CL
    Leuk Res; 2008 Nov; 32(11):1783-6. PubMed ID: 18455791
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy-related acute myeloid leukaemia with mutated NPM1: treatment induced or de novo in origin?
    Falini B
    Leukemia; 2008 May; 22(5):891-2. PubMed ID: 18478020
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis.
    Bornhäuser M; Mohr B; Oelschlaegel U; Bornhäuser P; Jacki S; Ehninger G; Thiede C
    Leukemia; 2007 Aug; 21(8):1824-6. PubMed ID: 17476275
    [No Abstract]   [Full Text] [Related]  

  • 14. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
    Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H; Bock O
    Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent chromosomal aberration at 12q15 in chronic idiopathic myelofibrosis with or without JAK2(V617F) mutation.
    Ohyashiki K; Tauchi T; Kuroda M; Kodama A; Ohyashiki JH
    Leukemia; 2007 Jul; 21(7):1578-80. PubMed ID: 17443223
    [No Abstract]   [Full Text] [Related]  

  • 17. Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.
    Hélias C; Struski S; Gervais C; Leymarie V; Mauvieux L; Herbrecht R; Lessard M
    Cancer Genet Cytogenet; 2008 Jan; 180(1):51-5. PubMed ID: 18068534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.
    Wolanskyj AP; Lasho TL; Schwager SM; McClure RF; Wadleigh M; Lee SJ; Gilliland DG; Tefferi A
    Br J Haematol; 2005 Oct; 131(2):208-13. PubMed ID: 16197451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.
    Tefferi A; Lasho TL; Schwager SM; Steensma DP; Mesa RA; Li CY; Wadleigh M; Gary Gilliland D
    Br J Haematol; 2005 Nov; 131(3):320-8. PubMed ID: 16225651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of c-kit and JAK2 gene mutations in t(8;21) acute myeloid leukemia].
    Li WY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):797-801. PubMed ID: 19176031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.